share_log

ArriVent BioPharma | DRS/A: Others

SEC announcement ·  Dec 6, 2023 05:01
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more